首页> 外文期刊>World Journal of Surgery: Official Journal of the Societe Internationale de Chirurgie, Collegium Internationale Chirurgiae Digestivae, and of the International Association of Endocrine Surgeons >Detection of disseminated medullary thyroid carcinoma cells in cervical lymph nodes by cytokeratin 20 reverse transcription-polymerase chain reaction.
【24h】

Detection of disseminated medullary thyroid carcinoma cells in cervical lymph nodes by cytokeratin 20 reverse transcription-polymerase chain reaction.

机译:通过细胞角蛋白20逆转录聚合酶链反应检测宫颈淋巴结中弥散性甲状腺髓样癌细胞。

获取原文
获取原文并翻译 | 示例
       

摘要

Local recurrence in differentiated and medullary thyroid carcinoma develops frequently from metastatic infiltration of cervical lymph nodes. Despite an aggressive surgical approach, postoperative calcitonin levels as biochemical evidence for residual cancer cells remain often elevated in patients with medullary thyroid carcinoma. In the present study, we compared the detection rates of disseminated medullary thyroid carcinoma cells in cervical lymph nodes by histopathology with reverse transcription-polymerase chain reaction (RT-PCR) amplification of cytokeratin 20 (CK20) transcripts as a more sensitive but still specific molecular parameter for residual thyroid cancer cells. Forty-two cervical lymph nodes obtained from 7 patients with CK20positive medullary thyroid carcinomas were cut into two halves, one used for conventional histology, the other subjected to RNA extraction and subsequent amplification of cytokeratin 20 transcripts. Matching results for CK20 RT-PCR and histopathology were found in 74% (31/42)of the examined lymph nodes (52% positive results, 48% negative results). Positive CK20 RT-PCR pointed to residual thyroid carcinoma cells in another 19% (8/42), in which no thyroid carcinoma cells were identified by histopathology. Histology and immunohistochemistry,however, identified tumor cells in 7% (3/42) of the analyzed lymph nodes, from which no CK20 transcript could be amplified (false-negative results). These data suggest that CK20 RT-PCR might be more sensitive to detect nodal involvement of CK20 positive medullary thyroid carcinomas than conventional histopathology. In combination with histology, it might help to identify patients with residual disease after surgery.
机译:分化型甲状腺髓样癌的局部复发经常由转移性宫颈淋巴结浸润发展而来。尽管采取了积极的手术方法,甲状腺髓样癌患者术后降钙素水平作为残留癌细胞的生化证据仍经常升高。在本研究中,我们比较了通过组织病理学和反转录-聚合酶链反应(RT-PCR)扩增的细胞角蛋白20(CK20)转录本作为更敏感但仍具特异性的分子在宫颈淋巴结中弥散性甲状腺髓样癌细胞的检测率残留甲状腺癌细胞的参数。将7例CK20阳性甲状腺髓样癌患者的42个颈淋巴结切成两半,一个用于常规组织学,另一个进行RNA提取并随后扩增细胞角蛋白20转录本。在74%(31/42)的淋巴结中发现了CK20 RT-PCR与组织病理学的匹配结果(阳性结果52%,阴性结果48%)。 CK20 RT-PCR阳性表明还有19%(8/42)的甲状腺癌残留,其中组织病理学未发现甲状腺癌细胞。但是,组织学和免疫组织化学方法在被分析的淋巴结中有7%(3/42)处发现了肿瘤细胞,因此无法扩增出CK20转录本(假阴性结果)。这些数据表明,与传统的组织病理学相比,CK20 RT-PCR对检测CK20阳性甲状腺髓样癌的淋巴结侵犯可能更为敏感。结合组织学,可能有助于识别术后残留疾病的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号